IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy — Stella

Recruiting

Back to Gastrointestinal Motility Disorder trials

Trial locations(1 site)

United States

University of Louisville, Louisville, Kentucky

Key details

Sponsor

University of Louisville

Enrollment target

~400 participants

Started

January 2020

Primary completion

January 2028

Age range

12 Years – 90 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov